These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 16847412)

  • 21. Recovery of fat following a switch to nucleoside reverse transcriptase inhibitor-sparing therapy in patients with lipoatrophy: results from the 96-week randomized ANRS 108 NoNuke Trial.
    Valantin MA; Lanoy E; Bentata M; Kalmykova O; Boutekadjirt A; Allavena C; Rozenbaum W; Peytavin G; Amellal B; Calvez V; Costagliola D; Katlama C;
    HIV Med; 2008 Oct; 9(8):625-35. PubMed ID: 18624724
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Distinct mechanisms for mitochondrial DNA loss in T and B lymphocytes from HIV-infected patients exposed to nucleoside reverse-transcriptase inhibitors and those naive to antiretroviral treatment.
    Maagaard A; Holberg-Petersen M; Løvgården G; Holm M; Pettersen FO; Kvale D
    J Infect Dis; 2008 Nov; 198(10):1474-81. PubMed ID: 18851688
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Uridine supplementation in the treatment of HIV lipoatrophy: results of ACTG 5229.
    McComsey GA; Walker UA; Budhathoki CB; Su Z; Currier JS; Kosmiski L; Naini LG; Charles S; Medvik K; Aberg JA;
    AIDS; 2010 Oct; 24(16):2507-15. PubMed ID: 20827170
    [TBL] [Abstract][Full Text] [Related]  

  • 24. HIV-associated lipodystrophy syndrome.
    Milinković A
    Coll Antropol; 2006 Dec; 30 Suppl 2():59-62. PubMed ID: 17508476
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Contribution of mitochondrial dysfunction and oxidative stress to cellular premature senescence induced by antiretroviral thymidine analogues.
    Caron M; Auclairt M; Vissian A; Vigouroux C; Capeau J
    Antivir Ther; 2008; 13(1):27-38. PubMed ID: 18389896
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A 6-month interruption of antiretroviral therapy improves adipose tissue function in HIV-infected patients: the ANRS EP29 Lipostop Study.
    Kim MJ; Leclercq P; Lanoy E; Cervera P; Antuna-Puente B; Maachi M; Dorofeev E; Slama L; Valantin MA; Costagliola D; Lombes A; Bastard JP; Capeau J
    Antivir Ther; 2007; 12(8):1273-83. PubMed ID: 18240867
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Differential gene expression indicates that 'buffalo hump' is a distinct adipose tissue disturbance in HIV-1-associated lipodystrophy.
    Guallar JP; Gallego-Escuredo JM; Domingo JC; Alegre M; Fontdevila J; Martínez E; Hammond EL; Domingo P; Giralt M; Villarroya F
    AIDS; 2008 Mar; 22(5):575-84. PubMed ID: 18316998
    [TBL] [Abstract][Full Text] [Related]  

  • 28. HIV-associated lipodystrophy: a review of underlying mechanisms and therapeutic options.
    Mallewa JE; Wilkins E; Vilar J; Mallewa M; Doran D; Back D; Pirmohamed M
    J Antimicrob Chemother; 2008 Oct; 62(4):648-60. PubMed ID: 18565973
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Pathogenesis of lipodystrophy and lipid abnormalities in patients taking antiretroviral therapy.
    Mallon PW
    AIDS Rev; 2007; 9(1):3-15. PubMed ID: 17474309
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Increased red cell corpuscular volume and hepatic mitochondrial function in NRTI-treated HIV infected patients.
    Sternfeld T; Lorenz A; Schmid M; Schlamp A; Demmelmair H; Koletzko B; Bogner JR
    Curr HIV Res; 2009 May; 7(3):336-9. PubMed ID: 19442131
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Symptomatic hyperlactatemia associated with nucleoside analogue reverse-transcriptase inhibitor use in HIV-infected patients: a report of 24 cases in a resource-limited setting (Uganda).
    Songa PM; Castelnuovo B; Mugasha EB; Ocama P; Kambugu A
    Clin Infect Dis; 2007 Aug; 45(4):514-7. PubMed ID: 17638205
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Nucleoside reverse-transcriptase inhibitor use, cirrhosis, and end-stage liver disease in HIV-infected patients.
    Remtulla RA; Decker CF
    Clin Infect Dis; 2008 Nov; 47(9):1233-4; author reply 1234. PubMed ID: 18831698
    [No Abstract]   [Full Text] [Related]  

  • 33. [(13)C]Methionine breath test as a marker for hepatic mitochondrial function in HIV-infected patients.
    Sternfeld T; Lorenz A; Schmid M; Schlamp A; Demmelmair H; Koletzko B; Bogner JR
    AIDS Res Hum Retroviruses; 2009 Dec; 25(12):1243-8. PubMed ID: 20001311
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Hyperlactataemia and hepatic steatosis: mitochondrial toxicity of nucleoside reverse transcriptase inhibitors.
    Pao D; Watson C; Peters B; Lucas SB; Miller RF
    Sex Transm Infect; 2001 Oct; 77(5):381-4. PubMed ID: 11588287
    [No Abstract]   [Full Text] [Related]  

  • 35. Mitochondrial dysfunction in alcoholic patients as assessed by breath analysis.
    Lauterburg BH; Liang D; Schwarzenbach FA; Breen KJ
    Hepatology; 1993 Mar; 17(3):418-22. PubMed ID: 8444415
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Acute renal failure and proximal renal tubular dysfuntion in a patient with acquired immunodeficiency syndrome treated with tenofovir].
    de la Prada FJ; Prados AM; Tugores A; Uriol M; Saus C; Morey A
    Nefrologia; 2006; 26(5):626-30. PubMed ID: 17117909
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Mitochondrial (mt)DNA changes in tissue may not be reflected by depletion of mtDNA in peripheral blood mononuclear cells in HIV-infected patients.
    Maagaard A; Holberg-Petersen M; Kollberg G; Oldfors A; Sandvik L; Bruun JN
    Antivir Ther; 2006; 11(5):601-8. PubMed ID: 16964828
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Impact of antiretroviral treatment on (13) C-methionine metabolism as a marker of hepatic mitochondrial function: a longitudinal study.
    Banasch M; Frank J; Serova K; Knyhala K; Kollar S; Potthoff A; Brockmeyer NH; Goetze O
    HIV Med; 2011 Jan; 12(1):40-5. PubMed ID: 20500232
    [TBL] [Abstract][Full Text] [Related]  

  • 39. HIV and mitochondrial toxicity in children.
    Foster C; Lyall H
    J Antimicrob Chemother; 2008 Jan; 61(1):8-12. PubMed ID: 17999978
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Longitudinal increases in waist circumference are associated with HIV-serostatus, independent of antiretroviral therapy.
    Brown TT; Chu H; Wang Z; Palella FJ; Kingsley L; Witt MD; Dobs AS
    AIDS; 2007 Aug; 21(13):1731-8. PubMed ID: 17690571
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.